OUTCOME OF FIRST-LINE TREATMENT WITH EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITOR (EGFR-TKI) AND FIRST-LINE CHEMOTHERAPY IN ADVANCED LUNG ADENOCARCINOMA: Abstract ID – 240


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles